Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel Sigma 1 Receptor Antagonists as Potential Therapeutics for Pain Management

Published:2020-12-29 Issue:1 Volume:64 Page:890-904
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Peng Youyi¹^ORCID,Zhang Qiang²,Welsh William J.¹²^ORCID

Affiliation:

1. Biomedical Informatics Shared Resource, Cancer Institute of New Jersey, Rutgers, The State University of New Jersey, 195 Little Albany Street, New Brunswick, New Jersey 08903, United States

2. Department of Pharmacology, Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, 661 Hoes Lane West, Piscataway, New Jersey 08854, United States

Funder

National Cancer Institute

New Jersey Health Foundation

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.0c01964

Reference50 articles.

1. Sigma receptors mediate the psychotomimetic effects of N-allylnormetazocine (SKF-10,047), but not its opioid agonistic-antagonistic properties

2. Purification, molecular cloning, and expression of the mammalian sigma1-binding site.

3. Cloning and Functional Characterization of a σ Receptor from Rat Brain

4. Cloning and Characterization of a Mouse σ1 Receptor

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical Evaluation of Sigma 1 Receptor Antagonists as a Novel Treatment for Painful Diabetic Neuropathy;ACS Pharmacology & Translational Science;2024-07-18

2. Machine learning models to predict ligand binding affinity for the orexin 1 receptor;Artificial Intelligence Chemistry;2024-06

3. Unexpected Cyclization Product Discovery from the Photoinduced Bioconjugation Chemistry between Tetrazole and Amine;Journal of the American Chemical Society;2024-01-08

4. The Sigma-1 Receptor as a Pharmacologic Chaperone: Energetics;Journal of Biosciences and Medicines;2024

5. Recent advances in drug discovery efforts targeting the sigma 1 receptor system: Implications for novel medications designed to reduce excessive drug and food seeking;Addiction Neuroscience;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3